Biotech Market Expansion in Europe.
Leaders That Launch: Episode 1
Building the leadership teams that launch in Europe
The Leaders That Launch series by Inizio Engage Executive Search Solutions explores the leadership decisions behind today’s most successful healthcare and biotech launches.
In Episode 1,
our expert panel breaks down what it takes to build high-performing leadership teams for European expansion. From cultural fluency to market sequencing, we uncover the biggest missteps companies make — and how to avoid them.
Who’s this for?
Biotech and biopharma executives preparing for EU market entry, launch, or scale-up — and anyone looking to build leadership teams that deliver impact from day one.
Bite-sized executive insights
Our host, Steve Cottrell (Chief Growth Officer, Inizio Engage), sets the scene: European expansion is full of opportunity – and complexity.
To succeed, you need leadership teams with deep local insight, strategic flexibility, and the ability to execute at speed.
We’ve edited the full episode into short, actionable clips so you can jump straight to the insight that matters most.
Jump straight to the insight that matters most.
1. What are the biggest misconceptions about building leadership teams in Europe?
We asked Benjamin Rapp, President,
Inizio Engage International
Key Insights:
- Europe is not one market — local legal, cultural, and leadership norms vary greatly.
- Language fluency doesn’t equal cultural fluency.
- Over-centralized org structures often backfire.
- Executive mobility is more complex than it seems.
Takeaway:
Avoid copying your US leadership model. Success requires local empowerment, cultural intelligence, and a flexible org design.
2. How does market prioritization shape executive hiring?
We asked Dean McAllister, President,
Inizio Biotech
Key Insights:
- Market sequencing matters — but so does leadership stamina.
- Look beyond credentials; assess how much energy, vision, and adaptability remain.
- The “talent-to-skill” ratio is crucial — past performance doesn’t guarantee future fit.
- Hire leaders who can scale with your company, not just launch the first market.
Takeaway:
Don’t just hire for today’s need. Invest in leadership that can evolve with your European strategy over time.
3. Who should you hire first?
We asked Lothar Helger, Head of Executive Search Solutions, Inizio Engage
Key Insights:
- In most cases, success starts with hiring a strong GM or VP – your first hire shapes the culture and drives the buildout.
- In rare diseases, a Head of Medical or MSL may be the priority – someone who can engage KOLs and guide early activity.
- Embedded solutions (like interim hires on Inizio Engage’s payroll) can bridge gaps before legal entities are established.
- Executive assessment is critical – it’s not just about experience, but strategic capacity, motivation, and execution power.
Takeaway:
Your first hire isn’t just a role – it’s your foundation. Overinvest in talent and lean on embedded expertise to de-risk early decisions.
4. What skills and experience should we be looking for in a biotech executive?
We asked Lothar Helger, Head of Executive Search Solutions, Inizio Engage
Key Insights:
- Deep market knowledge is non-negotiable – including healthcare systems, market access, and the specific disease area.
- Successful launch experience is critical – but so is learning from failed launches.
- Executives must match the company’s growth phase, with the ability to scale in fast-paced, evolving environments.
- Leaders should be cultural magnets — attracting top talent while representing the company with credibility across regions.
Takeaway:
Look for senior leaders with proven launch experience and the agility to operate at biotech speed – they set the tone, the culture, and the trajectory.
5. Speed vs. Precision – Do You Have to Choose?
We asked Dean McAllister, President,
Inizio Biotech
Key Insights:
- You don’t have to choose between moving fast and hiring right.
- Embedded partners like Inizio Engage bring both strategic oversight and executional muscle.
- A blended model of internal leaders + external expertise enables scalable launch support.
- Tailored staffing and strategic guidance ensure countries can come online at their own pace –without delay or compromise. >
Takeaway:
Avoid copying your US leadership model. Success requires local empowerment, cultural intelligence, and a flexible org design.
6. What defines post-hire success in the first 6–12 months?
We asked Benjamin Rapp, President,
Inizio Engage International
Insights:
- Success begins with clarity: strategic alignment and a strong understanding of the European landscape.
- Credibility matters – internally with HQ and affiliates, and externally with KOLs, payers, and regulators.
- Early operational wins and cultural integration signal strong execution and leadership.
- Effective leaders build teams, lay scalable foundations, and manage for the long term – not just the now.
Takeaway:
Set KPIs that go beyond commercial results. True success in the first 6–12 months means integration, credibility, capability-building, and strategic execution.
7. When Is the Right Time to Start Building Your Leadership Team in Europe?
We asked Dean McAllister and Lothar Helger
Key Insights:
- Don’t rush – but don’t wait too long. Timing is critical to ensure readiness and avoid last-minute pressure.
- Avoid hiring too early before regulatory clarity (especially US and EU filings) – it can lead to misalignment or wasted resources.
- Plan backwards from your ideal launch date – factor in 3–6 months for recruitment, notice periods, and onboarding.
- One year ahead of launch is a good benchmark – it gives space for market prep, KOL engagement, and brand planning.
Takeaway:
Start early – but strategically. Speak with partners like Inizio Engage as soon as possible to build the right leadership roadmap and resource plan.
8. What unique leadership recruitment challenges do you see in biotech compared to more established pharma companies?
We asked Benjamin Rapp and Dean McAllister
Key Insights:
- Biotechs often lack brand recognition – so attracting top talent requires strong storytelling and cultural clarity.
- For executive search partners, deeply understanding the biotech’s vision and positioning is critical to engage the right candidates.
- Internal talent audits can reveal gaps – so many biotechs need to go external to find launch-ready leadership.
- De-risking with interim leadership (via embedded models) is a smart strategy while scaling.
Takeaway:
Biotechs must balance agility with credibility. With no legacy brand to lean on, leadership hiring becomes a strategic differentiator – and a partner like Inizio Engage helps fill the gap with precision.
9. What's the most important leadership decision a biotech company can make when they're expanding into the European market?
Key Insights:
- Over-invest in your first cornerstone hire – don’t compromise on quality.
- Choosing the right partner is just as important as choosing the right leader.
- Go with someone who’s been there before – experience matters.
Takeaway:
Expansion into Europe is a strategic leap. Do it with the right leaders – and the right search partner – and you’ll build a foundation for long-term success.
Ready to Launch with Confidence?
-
Executive Search Solutions
Inizio Engage Executive Search Solutions connects you with high-impact executives who are ready to drive your launch, expansion, or transformation across Europe.
With deep healthcare expertise and global reach, we move fast – without compromising on quality and precision.
-
Need more than executive talent?
As a commercial outsourcing (CSO) partner, Inizio Engage (formerly Ashfield Engage) has 30+ years’ experience engaging primary and specialist healthcare professionals as well as pharmacists across the UK & Ireland and across many therapeutic areas.
And when early scientific engagement matters most, our MSL Solutions help build credibility from day one.
Let’s build your leadership team — and your future in Europe.